Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/9/2020
OmniSYS offers free resource to help pharmacies provide COVID-19 testing
Pharmacists will have free access to the OmniSYS Training Center to operationalize COVID-19 testing. - 4/8/2020
CVS Pharmacy donates $5M worth of seasonal treats to local communities
CVS Pharmacy field leaders and managers will select local organizations to receive donations. - 4/8/2020
Aurobindo gets FDA OK for generic Zanaflex
Aurobindo's generic Zanaflex will be available in three dosage strengths. - 4/7/2020
NACDS' online maps display state-by-state status of action amid COVID-19
NACDS’ online maps show further action is needed to remove barriers to pharmacy patient care immediately. - 4/7/2020
NCPA recognizes front-line pharmacists with new video
NCPA CEO Doug Hoey applauds community pharmacists for their efforts in the fight against COVID-19. - 4/6/2020
CVS Health expands COVID-19 testing sites throughout Massachusetts
CVS Health is providing Massachusetts residents with on-the-spot COVID-19 testing and results at no cost, using the new Abbott ID NOW COVID-19 test. - 4/6/2020
Innovation names Richardson CEO
Innovation co-president Marvin Richardson takes over as CEO on April 25, succeeding Mary Reno, and co-president Tom Boyer will become chief strategy officer. - 4/6/2020
Novartis terminates sale of Sandoz U.S. generic oral solids, dermatology portfolio to Aurobindo
Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business. - 4/5/2020
NACDS praises new Indiana law as boon for access to pharmacy services
A new Indiana law allows a pharmacist to substitute a therapeutic alternative for epinephrine products. - 4/5/2020
Lupin launches generic Myfortic
Mycophenolic acid delayed-release tablets had a market value of roughly $156 million, according to IQVIA data from February.
